How preoperative QFR might affect graft outcomes after CABG
Official title: The Impact of Preoperative Quantitative Flow Reserve (QFR) on Early Postoperative Radial Artery Graft Outcomes in Coronary Artery Bypass Grafting
Run by Peking University Third Hospital · NCT07669987 · Data updated 2026-11-12
This study looks to see if measuring Quantitative Flow Reserve before surgery helps improve graft results and reduce heart- and brain-related events in people having coronary artery bypass grafting.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | Peking University Third Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | January 1, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | June 25, 2026 |
| Trial ID | NCT07669987 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 with angina severe enough to warrant CABG and available preoperative QFR data, with multivessel stenosis in major coronary arteries.
✕Probably not a fit
Patients who do not experience graft-related issues or MACE within one year or who do not undergo QFR-informed modifications may see no added benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study evaluating the potential impact of preoperative Quantitative Flow Reserve (QFR) assessment on early graft performance after CABG. Researchers will follow adults aged 18 to 80 who are scheduled for CABG and have preoperative QFR data, tracking graft patency and major adverse cardiac and cerebrovascular events (MACE) for one year. Data collection will occur through regular follow-up visits and patient-reported health questionnaires. The study is conducted at Peking University Third Hospital, with no stated collaborators, focusing on patients with significant multivessel coronary disease. Results could inform whether preoperative QFR informs surgical planning and postoperative risk.
Why it matters
Potential benefit: If successful, preoperative QFR assessment could help predict graft performance and reduce future cardiac or cerebrovascular events after CABG.
How similar studies have gone: Prior research has explored QFR in planning revascularization, with mixed results; this study adds observational data in the CABG setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 to 80 years. * Patients whose angina pectoris significantly affects daily life and work, and for whom conservative medical treatment is ineffective, requiring coronary artery bypass grafting (CABG). * Preoperative coronary angiography data are available for quantitative flow ratio (QFR) analysis. * Patients with severe stenosis, defined as greater than 70% stenosis, in the three main coronary artery branches, including the left anterior descending artery, circumflex artery, and right coronary artery, with or without left main coronary artery stenosis greater than 50%. Exclusion Criteria: * Patients who cannot tolerate CABG due to comorbidities or complications. * Patients requiring urgent CABG or percutaneous coronary intervention (PCI). * Patients with significant congestive heart failure or hemodynamic instability. * Patients with a history of previous CABG or PCI within the past 6 months. * Patients who have experienced a stroke within the past 6 months. * Patients requiring concurrent cardiac procedures, such as valve surgery, maze surgery, radiofrequency ablation, or pacemaker implantation. * Patients with allergies to contrast agents or antiplatelet medications, or with contraindications to antiplatelet medications due to bleeding risks. * Patients with a significant history of bleeding, marked leukopenia, neutropenia, thrombocytopenia, anemia, or bleeding diathesis. * Patients currently participating in other prospective clinical studies. * Patients who are unwilling to participate in this study.
Where it's running
-
Peking university third hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Tong Ding, MD
- Email: dt1067723747@gmail.com
- Phone: +8613132150173
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating blood flow in hand arteries using advanced MRI techniques
This study is testing a new MRI method to see how blood flows in the hands of healthy people and those who have had specific surgeries, to help improve care for hand transplants.
-
Surgery With Prehabilitation, Direct Surgery, or Rehab for Hip Impingement
This study tests three approaches for femoroacetabular impingement to see which helps hip pain and function best: surgery with prehab, surgery without prehab, or rehabilitation alone.
-
Disposable noninvasive skin closure to help healing and reduce scarring after plastic surgery
This study tests a disposable noninvasive skin closure device on one side of a plastic surgery incision to see if it helps wounds heal better and results in less scarring.
-
Systemic Sclerosis Patient Cohort: Longitudinal Observation at Peking University Third Hospital
This observational study follows people with systemic sclerosis to understand how the disease progresses and to identify markers and potential targets for treatment.
-
Motor imagery–enhanced rehab after ACL reconstruction
This study tests whether mentally practicing movement can improve knee function and brain activity after ACL reconstruction, in comparison with standard rehab.
-
Effects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA
This study tests whether a portable knee-training robot with a compliant vs. rigid stiffness setting improves knee strength in children with spinal muscular atrophy, using each child’s other leg as a comparison.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.